Brain Connectivity Gradients Alterations in Discordant Cerebrospinal Fluid Profile for Alzheimer's Disease Biomarkers is a research paper published in Human Brain Mapping (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Grant: IZSEZ0_229208
Fondazione Cassa di Risparmio di Padova e Rovigo
Grant: 68076
National Institutes of Health
Grant: U01 AG024904
NEUROCONN
Grant: RF-2018-1236689
MUR PRIN 2022
Grant: 202292PHR2
Swiss National Science Foundation
Grant: 229208
HORIZON-INFRA-2022
Grant: 101147319
HORIZON-ERC-SyG
Grant: 101071900
DOD ADNI
Grant: W81XWH-12-2-0012
Alzheimer's Drug Discovery Foundation
Alzheimer's Association
Biogen
Pfizer Inc.
Araclon Biotech
Canadian Institutes of Health Research
GE Healthcare
Lundbeck
Neurotrack Technologies
Pfizer
Takeda Pharmaceutical Company
AbbVie
Eisai Canada
Eisai Inc.
IXICO Ltd.
MIUR D.M. 737/2021
Merck & Co. Inc.
National Institute on Aging
Transition Therapeutics
Alzheimer's Drug Discovery Foundation
EuroImmun
F. Hoffmann-La Roche Ltd.
Foundation for the National Institutes of Health
Genentech Inc.
Johnson & Johnson Pharmaceutical Research & Development LLC.
Piramal Imaging
The Ministero della Salute Italiano
Bristol-Myers Squibb Company
CereSpir Inc.
Elan Pharmaceuticals Inc.
Janssen Alzheimer Immunotherapy Research & Development LLC.
Alzheimer's Association
Cogstate
DoD Alzheimer's Disease Neuroimaging Initiative
Fujirebio
H. Lundbeck A/S
Meso Scale Diagnostics LLC.
National Institute of Biomedical Imaging and Bioengineering
Alzheimer's Disease Neuroimaging Initiative
BioClinica Inc.
Eli Lilly and Company
Fujirebio US
NIBIB NIH HHS
CIHR
Lumosity
NeuroRx Research
Northern California Institute for Research and Education
Novartis Pharmaceuticals Corporation
Servier
Alzheimer's Association
GE Healthcare
Elan Pharmaceuticals Inc.
AbbVie
Cogstate
NIBIB NIH HHS
Janssen Alzheimer Immunotherapy Research & Development LLC.
Pfizer Inc.
BioClinica Inc.
MIUR D.M. 737/2021
EuroImmun
Biogen
Johnson & Johnson Pharmaceutical Research & Development LLC.
CIHR
Alzheimer's Disease Neuroimaging Initiative
Alzheimer's Drug Discovery Foundation
Servier
Lumosity
Bristol-Myers Squibb Company
Piramal Imaging
Meso Scale Diagnostics LLC.
Takeda Pharmaceutical Company
Araclon Biotech
Merck & Co. Inc.
Novartis Pharmaceuticals Corporation
Northern California Institute for Research and Education
Transition Therapeutics
F. Hoffmann-La Roche Ltd.
The Ministero della Salute Italiano
Eli Lilly and Company
Foundation for the National Institutes of Health
CereSpir Inc.
IXICO Ltd.
NeuroRx Research
Neurotrack Technologies
Fujirebio
Lundbeck
Genentech Inc.
Eisai Inc.
FWCI
0.76
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords